The LP of IBD patients is characterized by elevated numbers of certain T cell subsets including naive T cells, CD4+ effector T cells, IFNγ‐producing CD8+ T cells, T regulatory cells, and ILC. This evidence concerns the gene CD8A and inflammatory bowel disease.